IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Rossari Biotech IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 496.49 Cr. The company is based in Mumbai and caters to Chemical - Speciality sector. Axis Bank , ICICI Securities are the merchant bankers of Rossari Biotech IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 18th December 2019.
Rossari Biotech IPO posted revenues of ₹ 600.94 Cr. and PAT of ₹ 65.20 Cr. in FY25 on annualised basis.
Revenue:
₹ 600.94 Cr.
EBITDA Margin:
18.00
% 
Net Worth: ₹ 286.67 Cr.
Market Capitalisation:
[●]
P/E:
33.81 times
P/BV: [●]
EV/EBITDA: 0.29 times
Financial results of Rossari Biotech IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY 20 | FY 19 | FY 18 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 471.15 | 249.84 | 164.95 | ||
| Net Worth | 286.67 | 123.81 | 87.08 | ||
| Total Debt | 60.95 | 3.80 | 20.00 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
600.94 | 516.21 | 299.06 | ||
EBITDA
EBITDA on annualised basis |
108.19 | 78.39 | 43.94 | ||
PAT
PAT on annualised basis |
65.20 | 45.68 | 25.40 | ||
Rossari Biotech IPO PAT Margin is 10.85 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Rossari Biotech IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY 20 | FY 19 | FY 18 |
|---|---|---|---|
| EBITDA Margin (%) | 18.00 | 15.19 | 14.69 |
| PAT Margin (%) | 10.85 | 8.85 | 8.49 |
| EPS (₹) | 13.42 | 9.44 | 5.25 |
| ROE (%) | 22.74 | 36.90 | 29.17 |
| ROCE (%) | [●] | [●] | [●] |
| ROA (%) | 13.84 | 18.28 | 15.40 |
| Debt to Equity | 0.21 | 0.03 | 0.23 |
The market Capitalisation of Rossari Biotech IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Rossari Biotech IPO prospectus highlights an Return on Equity (ROE) of 22.74 % , Return on Assets (ROA) of 13.84 %, and an EBITDA Margin of 18.00 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Rossari Biotech IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Rossari Biotech IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Rossari Biotech IPO has a Price-to-Earnings (PE) ratio of 33.81 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Rossari Biotech IPO reported revenue of ₹ 603.82 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Rossari Biotech IPO provide insights into sales growth, market demand, and business scalability.
Rossari Biotech recorded an EBITDA of ₹ 108.19 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Rossari Biotech Profit After Tax (PAT) is ₹ 65.20 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 600.94 Cr.
EBITDA Margin:
18.00
%
Net Worth: ₹ 286.67 Cr.
Market Capitalisation:
[●]
P/E:
33.81 times
P/BV: [●]
EV/EBITDA:
[●]
Rossari Biotech operates in Chemical - Speciality and Specialty Chemicals Manufacturing Company. The Issue is listed on BSE,NSE in Jul, 2020. Rossari Biotech IPO size was 496.49 with Issue price of 425.00 .
Merchant Banker(s) of Rossari Biotech IPO: Axis Bank Limited , ICICI Securities Limited
Rossari Biotech IPO subscription was 79.37 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Rossari Biotech IPO listed at a listing price of 742.35 against the offer price of 425.00.
The current market price of Rossari Biotech is 743.30.
Why Us?
